Frost Health LawAlabama Attorney • Pharmacist • Healthcare Executive

340B • Pharmacy Litigation • Massachusetts • Data Privacy • Patient Access

Massachusetts Hospitals Sue Lilly Over 340B Claims Data Requirements

Five Massachusetts hospitals sued Eli Lilly October 27 over claims data requirements tied to 340B pricing. According to their complaint, Lilly withheld discounts after they declined to submit in-house pharmacy and medical claims through 340B ESP. The hospitals assert Massachusetts consumer-protection and unjust-enrichment claims and seek injunctions and monetary relief. These are allegations, not findings. Pharmacy leaders should review purchasing exposure and data-sharing controls. Later docket orders were not verified for this report.

By Toby C. “Chad” Frost • October 28, 2026
2 min read

A newly filed Massachusetts case

Five hospitals filed suit against Eli Lilly in the U.S. District Court for the District of Massachusetts on October 27, 2026. The plaintiffs include Massachusetts General Hospital, Brigham and Women’s Hospital, Salem Hospital, UMass Memorial Medical Center, and UMass Memorial Health–Harrington Hospital. The case is No. 1:26-cv-14855.1

According to the complaint, Lilly conditioned access to 340B ceiling prices on submission of in-house pharmacy and medical claims through 340B ESP and withdrew discounts when the hospitals declined. The plaintiffs allege that the demands and platform terms create privacy, security, and financial risks. Their counts assert violations of Massachusetts consumer-protection law and unjust enrichment. Those disputed assertions remain allegations.1

Requested relief requires a court decision

The complaint requests preliminary and permanent injunctions, damages, and restitution. The filing itself does not grant that relief or establish that Lilly acted unlawfully. No subsequent docket order was verified for this report; the status described here is limited to the complaint.2

Connect purchasing decisions with data governance

Chad’s analysis: Review a manufacturer’s pricing conditions and proposed data transfers together. Identify the requested fields, authorized users, permitted uses, retention terms, and downstream disclosures. Document who approves a submission and model the purchasing exposure if discounts become unavailable. Keep pharmacy, finance, privacy, and legal reviewers working from the same facts. Record actual invoices, access notices, and patient-support impacts separately from projected losses. Any operational response should reflect applicable agreements and verified court orders.

Source notes

  1. Complaint at 1, ¶¶ 4–12, 109–23, 154–73, Gen. Hosp. Corp. v. Eli Lilly & Co., No. 1:26-cv-14855 (D. Mass. Oct. 27, 2026), ECF No. 1.
  2. Complaint, Prayer for Relief, at 46–47, Gen. Hosp. Corp. v. Eli Lilly & Co., No. 1:26-cv-14855 (D. Mass. Oct. 27, 2026), ECF No. 1.